References
- SoveriniSDe BenedittisCPapayannidisCDrug resistance and BCR-ABL kinase domain mutations in Philadelphia chromosome-positive acute lymphoblastic leukemia from the imatinib to the second-generation tyrosine kinase inhibitor era: the main changes are in the type of mutations, but not in the frequency of mutation involvementCancer201412071002100924382642
- ModiHLiLChuSRossiJYeeJKBhatiaRInhibition of Grb2 expression demonstrates an important role in BCR-ABL-mediated MAPK activation and transformation of primary human hematopoietic cellsLeukemia201125230531221072043
- GesbertFSellersWRSignorettiSLodaMGriffinJDBCR/ABL regulates expression of the cyclin-dependent kinase inhibitor p27Kip1 through the phosphatidylinositol 3-kinase/AKT pathwayJ Biol Chem200027550392233923011010972
- DanialNNRothmanPJAK-STAT signaling activated by Abl oncogenesOncogene200019212523253110851051
- Liu-DumlaoTKantarjianHThomasDAO’BrienSRavandiFPhiladelphia-positive acute lymphoblastic leukemia: current treatment optionsCurr Oncol Rep201214538739422669492
- MillerGDBrunoBJLimCSResistant mutations in CML and Ph(+) ALL – role of ponatinibBiologics2014824325425349473
- Olsson-StrömbergUHermanssonMLundánTMolecular monitoring and mutation analysis of patients with advanced phase CML and Ph+ ALL receiving dasatinibEur J Haematol201085539940420659155
- MüllerMCCrossNCErbenPHarmonization of molecular monitoring of CML therapy in EuropeLeukemia200923111957196319710700
- ChenHYGeZWuYJImmunophenotypic analysis of Philadelphia chromosome positive acute lymphoblastic leukaemia in adultsZhongguo Shi Yan Xue Ye Xue Za Zhi2010183714717 Chinese20561435
- HochhausAKreilSCorbinASMolecular and chromosomal mechanisms of resistance to imatinib (STI571) therapyLeukemia200216112190219612399961
- KurzrockRKantarjianHMDrukerBJTalpazMPhiladelphia chromosome-positive leukemias: from basic mechanisms to molecular therapeuticsAnn Intern Med20031381081983012755554
- ShahNPNicollJMNagarBMultiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemiaCancer Cell20022211712512204532
- JohanssonBFioretosTMitelmanFCytogenetic and molecular genetic evolution of chronic myeloid leukemiaActa Haematol20021072769411919388
- PfeiferHLangeTWystubSPrevalence and dynamics of bcr-abl kinase domain mutations during imatinib treatment differ in patients with newly diagnosed and recurrent bcr-abl positive acute lymphoblastic leukemiaLeukemia20122671475148122230800
- AggouneDToscaLSorelNModeling the influence of stromal microenvironment in the selection of ENU-induced BCR-ABL1 mutants by tyrosine kinase inhibitorsOncoscience201411576825593988
- ChuiCMLiKYangMPlatelet-derived growth factor up-regulates the expression of transcription factors NF-E2, GATA-1 and c-Fos in megakaryocytic cell linesCytokine2003212516412670444
- ZhuangJHawkinsSFGlennMAAkt is activated in chronic lymphocytic leukemia cells and delivers a pro-survival signal: the therapeutic potential of Akt inhibitionHaematologica201095111011819713228
- PellicanoFSimaraPSinclairAThe MEK inhibitor PD184352 enhances BMS-214662-induced apoptosis in CD34+ CML stem/progenitor cellsLeukemia20112571159116721483442
- BaerCKernWKochSUltra-deep sequencing leads to earlier and more sensitive detection of the tyrosine kinase inhibitor resistance mutation T315I in chronic myeloid leukemiaHaematologica2016101783083827102501
- SeniorMFDA halts then allows sales of Ariad’s leukemia medicationNat Biotechnol201432191124406915
- PemovskaTJohnsonEKontroMAxitinib effectively inhibits BCR-ABL1(T315I) with a distinct binding conformationNature2015519754110210525686603
- GilesFJCortesJJonesDBergstromDKantarjianHFreedmanSJMK-0457, a novel kinase inhibitor, is active in patients with chronic myeloid leukemia or acute lymphocytic leukemia with the T315I BCR-ABL mutationBlood2007109250050216990603
- PengCBrainJHuYInhibition of heat shock protein 90 prolongs survival of mice with BCR-ABL-T315I-induced leukemia and suppresses leukemic stem cellsBlood2007110267868517395781